跳至主要内容
临床试验/NCT02486757
NCT02486757已完成早期 1 期

Investigation of Female Reproductive Hormone Dynamics During Adolescence

Massachusetts General Hospital1 个研究点 分布在 1 个国家目标入组 9 人开始时间: 2015年4月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
早期 1 期
状态
已完成
入组人数
9
试验地点
1
主要终点
Ovulation in Cycle 2

研究概览

简要总结

Irregular menstrual cycles are common in girls for several years after their first menstrual period. The cause of abnormal menstrual cycles during this time is not well-understood. The purpose of this study is to: 1) monitor girls during a menstrual cycle (with blood and urine sampling and serial pelvic ultrasounds) to identify those girls who do not ovulate (release of an egg from the ovary), and 2) determine whether cycles can be corrected by treating girls with a short course of low-dose estrogen and progesterone.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Basic Science
盲法
None

入排标准

年龄范围
12 Years 至 16 Years(Child)
性别
Female
接受健康志愿者

入选标准

  • no more than 3 ½ years postmenarchal

排除标准

  • Subjects currently on or previously treated with medications that may affect reproductive hormones (eg birth control pills).
  • Subjects with severe acne or hirsutism
  • Subjects who exercise excessively (running > 20 miles/week or its equivalent)
  • Subjects with any of the following medical conditions: diabetes, hypertension, hyperlipidemia, valvular heart disease, lupus, rheumatoid arthritis, migraine headaches with aura, undiagnosed breast mass, inflammatory bowel disease, gallbladder disease, sickle cell disease, or thrombophilia.
  • Current smoker
  • History of deep venous thrombosis or pulmonary embolism in subject or first-degree relative

研究组 & 干预措施

Interventional

Experimental

estradiol 50 mcg transdermal patch x 7 days oral micronized progesterone 0.5 mg/kg/dose TID x 7 days

干预措施: micronized progesterone (Drug)

Interventional

Experimental

estradiol 50 mcg transdermal patch x 7 days oral micronized progesterone 0.5 mg/kg/dose TID x 7 days

干预措施: transdermal estradiol (Drug)

结局指标

主要结局

Ovulation in Cycle 2

时间窗: 20-40 days

serum progesterone \> 3 ng/ml or presence of corpus luteum on pelvic ultrasound

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Janet E. Hall, MD

Professor of Medicine

Massachusetts General Hospital

研究点 (1)

Loading locations...

相似试验